2023
DOI: 10.1002/jgh3.12949
|View full text |Cite
|
Sign up to set email alerts
|

How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis

Masanori Atsukawa,
Akihito Tsubota,
Yuichi Tamura
et al.

Abstract: The vertical and horizontal broken lines indicate the pre‐revised criteria, whereas the vertical and horizontal solid lines indicate the 2022 European Society of Cardiology/European Respiratory Society criteria.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…The PAC can differentiate portopulmonary hypertension (PoPH) from other causes of pulmonary hypertension [8 ▪ ,13]. PoPH occurs in about 5–10% of liver transplantation recipients and is associated with poor prognosis [6,17,42,45,77]. A mean PAP of more than 50 mmHg before skin incision is an indication for case cancellation [1 ▪▪ ,42,45].…”
Section: Pulmonary Artery Cathetermentioning
confidence: 99%
“…The PAC can differentiate portopulmonary hypertension (PoPH) from other causes of pulmonary hypertension [8 ▪ ,13]. PoPH occurs in about 5–10% of liver transplantation recipients and is associated with poor prognosis [6,17,42,45,77]. A mean PAP of more than 50 mmHg before skin incision is an indication for case cancellation [1 ▪▪ ,42,45].…”
Section: Pulmonary Artery Cathetermentioning
confidence: 99%